FDA Warns of Risks Linked to Gadolinium-based Contrast Agents Used in MRI Scans
News
The U.S. Food and Drug Administration (FDA) has updated a safety bulletin about gadolinium-based contrast agents (GBCAs), after studies raised new concerns about them. Doctors often use GBCAs ... Read more